Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Luskin, Marlise R."'
Autor:
Aldoss I; City of Hope National Medical Center, Duarte, California, United States., Roloff GW; The University of Chicago, Chicago, Illinois, United States., Faramand RG; Moffitt Cancer Center, Tampa, Florida, United States., Kopmar NE; University of Washington, Seattle, Washington, United States., Lin C; Duke University School of Medicine, Durham, North Carolina, United States., Advani AS; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States., Dekker SE; Fred Hutchinson Cancer Center / University of Washington, Seattle, Washington, United States., Gupta VK; UCLA, Los Angeles, California, United States., O'Connor TE; Loyola University Medical Center, Maywood, Illinois, United States., Jeyakumar N; Stanford University, Stanford, California, United States., Muhsen IN; Baylor College of Medicine, Houston, Texas, United States., Valtis YK; Memorial Sloan Kettering Cancer Institute, New York city, New York, United States., Zhang A; Stanford University School of Medicine, Palo Alto, California, United States., Miller K; Stanford University School of Medicine, Stanford, California, United States., Sutherland KC; Stanford University School of Medicine, Stanford, California, United States., Dykes KC; University of California, San Diego, La Jolla, California, United States., Ahmed M; Cedars Sinai Medical Center, Houston, Texas, United States., Chen EC; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Zambrano H; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Bradshaw D; Georgia Cancer Center at Augusta University, Augusta, Georgia, United States., Mercadal S; University of Utah/ Huntsman Cancer Hospital, Salt Lake City, Utah, United States., Schwartz MS; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Tracy SI; University of Minnesota, Minneapolis, Minnesota, United States., Dholaria B; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Kubiak MJ; Georgia Cancer Center of Augusta University, Augusta, Georgia, United States., Mukherjee A; Oncology Hematology Care, Cincinnati, Ohio, United States., Majhail NS; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Battiwalla M; Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Nashville, Tennessee, United States., Mountjoy L; Colorado Blood Cancer Institute, Denver, Colorado, United States., Malik SA; Texas Transplant Institute, Austin, Texas, United States., Mathews J; Sarah Cannon Transplant and Cellular Therapy Program, Dallas, Texas, United States., Shaughnessy PJ; Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital San Antonio, TX, San Antonio, Texas, United States., Logan A; University of California San Francisco, San Francisco, California, United States., Ladha A; University of Southern California, Los Angeles, California, United States., Stefan M; Cleveland Clinic, Cleveland, Ohio, United States., Guzowski C; Northside Hospital, Atlanta, Georgia, United States., Hoeg RT; UC Davis, Sacramento, California, United States., Hilal T; Mayo Clinic, Phoenix, Arizona, United States., Moore J; University of Rochester Medical Center, Rochester, New York, United States., Connor M; University of Pennsylvania, Philadelphia, Pennsylvania, United States., O'Dwyer KM; University of Rochester Medical Center, Rochester, New York, United States., Hill LC; Baylor College of Medicine, Houston, Texas, United States., Tsai SB; Loyola University Medical Center, Maywood, Illinois, United States., Sasine JP; Cedars-Sinai Medical Center, Los Angeles, California, United States., Solh MM; The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States., Lee CJ; University of Utah; Huntsman Cancer Institute, United States., Kota V; Georgia Cancer Center at Augusta University, Augusta, Georgia, United States., Koura D; University of California, San Diego, La Jolla, California, United States., Veeraputhiran M; University of Arkansas Medical Center, Little Rock, Arkansas, United States., Blunk B; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Oliai C; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States., Leonard JT; Oregon Health Sciences, Portland, Oregon, United States., Frey NV; Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States., Park JH; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Luskin MR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bachanova V; University of Minnesota, Minneapolis, Minnesota, United States., Galal A; Atlantic Health Network, Morristown, New Jersey, United States., Bishop MR; University of Chicago, Chicago, Illinois, United States., Stock W; University of Chicago, Chicago, Illinois, United States., Cassaday RD; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Pullarkat VA; City of Hope Medical Center, Duarte, California, United States., Shah BD; Moffitt Cancer Center, Tampa, Florida, United States., Muffly L; Stanford University, Stanford, California, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Boissel N; Hématologie Clinique, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Luskin MR; Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stelljes M; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Advani AS; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ribera JM; Clinical Hematology Department, Institut Catalá d'Oncologia-Hospital Germans Trias i Pujol, Jose Carreras Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain., Marks DI; Bristol Haematology and Oncology Center, University Hospitals Bristol National Health Service Trust, Bristol, UK.
Publikováno v:
Cancer [Cancer] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Jann JC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Cancer Program, Broad Institute, Cambridge, MA, 02142, USA., Hergott CB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Winkler M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Element Iowa City (JMI Laboratories), North Liberty, IA, 52317, USA., Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Braun B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Charles A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Copson KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Barua S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Meggendorfer M; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Nadarajah N; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Haferlach T; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. Maximilian_Stahl@dfci.harvard.edu., Tothova Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. Zuzana_Tothova@dfci.harvard.edu.; Cancer Program, Broad Institute, Cambridge, MA, 02142, USA. Zuzana_Tothova@dfci.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Jul 20. Date of Electronic Publication: 2024 Jul 20.
Autor:
Vedula RS; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Karp HQ; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Koob J; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States., Lim F; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Garcia JS; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Winer ES; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Luskin MR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Ghiaur G; Johns Hopkins University, Baltimore, Maryland, United States., Kim AS; Brigham and Women's Hospital, United States., Beppu LW; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Sala-Torra O; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Radich JP; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Gootenberg JS; McGovern Institute, United States., Abudayyeh O; Harvard Medical School, Cambridge, Massachusetts, United States., Zhang F; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States., Lindsley RC; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.
Publikováno v:
Blood [Blood] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
Autor:
Shimony S; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel., Garcia JS; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Chen EC; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Luskin MR; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stahl M; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., DeAngelo DJ; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stone RM; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lindsley RC; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. coleman_lindsley@dfci.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1494-1500. Date of Electronic Publication: 2024 Mar 27.
Autor:
Hantel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brunner AM; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Plascak JJ; Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH, USA., Uno H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Varela JC; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rebbeck TR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lathan CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 01; Vol. 116 (7), pp. 1178-1184.
Autor:
Shimony S; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Fay CJ; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA., Luskin MR; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA., Lane AA; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2803-2812.
Autor:
Winter PS; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ramseier ML; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Navia AW; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Saksena S; Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.; Computational and Systems Biology Program, MIT, Cambridge, MA, USA., Strouf H; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Senhaji N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., DenAdel A; Center for Computational Molecular Biology, Brown University, Providence, RI, USA.; Department of Biostatistics, Brown University, Providence, RI, USA., Mirza M; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., An HH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bilal L; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Dennis P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leahy CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shigemori K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Galves-Reyes J; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Zhang Y; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Department of Biological Engineering, MIT, Cambridge, MA, USA., Powers F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mulugeta N; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Gupta AJ; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Calistri N; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Van Scoyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jones K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stevenson KE; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA USA., Ren S; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Couturier CP; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Amini AP; Microsoft Research, Cambridge, MA, USA., Raghavan S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kimmerling RJ; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Stevens MM; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA., Crawford L; Center for Computational Molecular Biology, Brown University, Providence, RI, USA.; Department of Biostatistics, Brown University, Providence, RI, USA.; Microsoft Research, Cambridge, MA, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Current Address: Merck and Co., Rahway, NJ, USA., Manalis SR; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biological Engineering, MIT, Cambridge, MA, USA., Shalek AK; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Institute for Medical Engineering & Science, MIT, Cambridge, MA, USA.; Department of Chemistry, MIT, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Murakami MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 10. Date of Electronic Publication: 2024 Jun 10.
Autor:
Luskin MR; Dana-Farber Cancer Institute.
Publikováno v:
Blood [Blood] 2024 Jun 06; Vol. 143 (23), pp. 2339-2340.
Autor:
Saygin C; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Zhang P; Division of Hematology, The Ohio State University, Columbus, Ohio., Stauber J; Albert Einstein College of Medicine-Montefiore Health System, New York, New York., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Sperling AS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts., Weeks LD; Dana-Farber Cancer Institute, Boston, Massachusetts., Luskin MR; Dana-Farber Cancer Institute, Boston, Massachusetts., Knepper TC; Moffitt Cancer Center, Tampa, Florida., Wanjari P; Department of Pathology, University of Chicago, Chicago, Illinois., Wang P; Department of Pathology, University of Chicago, Chicago, Illinois., Lager AM; Department of Pathology, University of Chicago, Chicago, Illinois., Fitzpatrick C; Department of Pathology, University of Chicago, Chicago, Illinois., Segal JP; Department of Pathology, University of Chicago, Chicago, Illinois., Gharghabi M; Division of Hematology, The Ohio State University, Columbus, Ohio., Gurbuxani S; Department of Pathology, University of Chicago, Chicago, Illinois., Venkataraman G; Department of Pathology, University of Chicago, Chicago, Illinois., Cheng JX; Department of Pathology, University of Chicago, Chicago, Illinois., Eisfelder BJ; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Bohorquez O; Albert Einstein College of Medicine-Montefiore Health System, New York, New York., Patel AA; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Umesh Nagalakshmi S; MedGenome, San Francisco, California., Jayaram S; MedGenome, San Francisco, California., Odenike OM; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Larson RA; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Godley LA; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois., Gibson CJ; Dana-Farber Cancer Institute, Boston, Massachusetts., Munshi NC; Dana-Farber Cancer Institute, Boston, Massachusetts., Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts., Greally JM; Albert Einstein College of Medicine-Montefiore Health System, New York, New York., Steidl U; Albert Einstein College of Medicine-Montefiore Health System, New York, New York., Lapalombella R; Division of Hematology, The Ohio State University, Columbus, Ohio., Shah BD; Moffitt Cancer Center, Tampa, Florida., Stock W; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 May 01; Vol. 5 (3), pp. 164-179.